With regard to fibrosis, collagen deposition was largely unaffected by the treatments, except interestingly, the HGF-neutralising antibody + c-MET inhibitor (Hi + Ci)-treated tumours, which showed a significant decrease in collagen content when compared with those treated with gemcitabine alone. The gene discussed is HGF; the disease is neoplasm.